137 related articles for article (PubMed ID: 18528290)
1. Heparanase-2 and syndecan-1 in colon cancer: the ugly ducklings or the beautiful swans?
Giordano RJ
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):716-8. PubMed ID: 18528290
[TBL] [Abstract][Full Text] [Related]
2. Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma.
Peretti T; Waisberg J; Mader AM; de Matos LL; da Costa RB; Conceição GM; Lopes AC; Nader HB; Pinhal MA
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):756-65. PubMed ID: 18617780
[TBL] [Abstract][Full Text] [Related]
3. [mRNA expression of syndecan-1 and heparanase in relation to tumor progression and prognosis of gastric carcinoma].
Ru GQ; Zhao ZS; Tang QL; Xu WJ
Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1062-4. PubMed ID: 17074248
[TBL] [Abstract][Full Text] [Related]
4. Syndecan-1 expression in gallbladder cancer and its prognostic significance.
Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
Eur Surg Res; 2008; 41(2):245-50. PubMed ID: 18544939
[TBL] [Abstract][Full Text] [Related]
5. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of syndecan-1 in prostate cancer.
Kiviniemi J; Kallajoki M; Kujala I; Matikainen MT; Alanen K; Jalkanen M; Salmivirta M
APMIS; 2004 Feb; 112(2):89-97. PubMed ID: 15056224
[TBL] [Abstract][Full Text] [Related]
7. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
8. [Syndecans in the diagnosis and prognosis of prostate cancer].
Contreras HR
Rev Med Chil; 2010 Jan; 138(1):95-101. PubMed ID: 20361158
[TBL] [Abstract][Full Text] [Related]
9. Mapping heparanase expression in the spinal cord of adult rats.
Zhang Y; Yeung MN; Liu J; Chau CH; Chan YS; Shum DK
J Comp Neurol; 2006 Jan; 494(2):345-57. PubMed ID: 16320243
[TBL] [Abstract][Full Text] [Related]
10. The role of heparanase in gastrointestinal cancer (Review).
Naomoto Y; Takaoka M; Okawa T; Nobuhisa T; Gunduz M; Tanaka N
Oncol Rep; 2005 Jul; 14(1):3-8. PubMed ID: 15944760
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
[TBL] [Abstract][Full Text] [Related]
12. Reduction of syndecan-1 expression during lip carcinogenesis.
Martínez A; Spencer ML; Brethauer U; Grez P; Marchesani FJ; Rojas IG
J Oral Pathol Med; 2009 Aug; 38(7):580-3. PubMed ID: 19473447
[TBL] [Abstract][Full Text] [Related]
13. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis.
Yang Y; Macleod V; Miao HQ; Theus A; Zhan F; Shaughnessy JD; Sawyer J; Li JP; Zcharia E; Vlodavsky I; Sanderson RD
J Biol Chem; 2007 May; 282(18):13326-33. PubMed ID: 17347152
[TBL] [Abstract][Full Text] [Related]
14. Heparanase regulates levels of syndecan-1 in the nucleus.
Chen L; Sanderson RD
PLoS One; 2009; 4(3):e4947. PubMed ID: 19305494
[TBL] [Abstract][Full Text] [Related]
15. Heparanase: one molecule with multiple functions in cancer progression.
Vlodavsky I; Elkin M; Abboud-Jarrous G; Levi-Adam F; Fuks L; Shafat I; Ilan N
Connect Tissue Res; 2008; 49(3):207-10. PubMed ID: 18661344
[TBL] [Abstract][Full Text] [Related]
16. Expression and clinical significance of syndecan-1 mRNA and HPA-1 mRNA in colorectal cancer detected with real-time fluorescent quantitative polymerase chain reaction.
Wang H; Si JL; Zhang XZ; Qi YQ; Niu ZY; Zhou CH
Chin J Cancer; 2010 Mar; 29(3):288-93. PubMed ID: 20193112
[TBL] [Abstract][Full Text] [Related]
17. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
[TBL] [Abstract][Full Text] [Related]
19. Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas.
Bologna-Molina R; Mosqueda-Taylor A; Lopez-Corella E; Almeida OP; Carrasco-Daza D; Garcia-Vazquez F; Farfan-Morales JE; Irigoyen-Camacho ME; Damián-Matsumura P
Oral Oncol; 2008 Aug; 44(8):805-11. PubMed ID: 18207448
[TBL] [Abstract][Full Text] [Related]
20. Heparanase expression: a potential ancillary diagnostic tool for distinguishing between malignant cells and reactive mesothelium in body cavity effusions.
Doviner V; Maly B; Reinhartz T; Vlodavsky I; Sherman Y
Cytopathology; 2007 Feb; 18(1):13-9. PubMed ID: 17250598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
